Business Is Boring

Business is Boring is a weekly podcast series presented by The Spinoff in association with Callaghan Innovation. Host Simon Pound speaks with innovators and commentators focused on the future of New Zealand. This week he talks to R&D programme leader Dr Peter Surman and Simone Hollier. Did you know that there is a local pharmaceutical company in the second stage of trials to use ketamine to treat depression - and that they're looking for people to participate in the trial? Well, here's a podcast for you dear listener. For this week's Business is Boring we meet two of the 800 workers at a very under-the-radar local drug maker. You might be surprised to know New Zealand has a big Pharma company, and you could also be forgiven for not knowing at all that it was almost sold off, but in this half hour chat we learn about the history, current work and future plans of Douglas Pharmaceuticals. Douglas is a family-owned drug giant, that since 1967 has grown from a company making generic drugs once they fell out of pat